Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.

Abstract

Our retrospective analysis explored the role of leukemia cutis (LC) in disease progression of chronic myelomonocytic leukemia (CMML). Of 108 patients with CMML, 11 patients (10.2%) had LC including its equivalent (2 patients). Four of these patients developed acute myeloid leukemia (AML) within 0-4 months. The remaining 7 patients demonstrated increased… (More)
DOI: 10.1016/j.leukres.2011.05.003

Topics

Cite this paper

@article{Mathew2012CutaneousMI, title={Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.}, author={Rahel A Mathew and John M. Bennett and Jane Jijun Liu and Rami S Komrokji and Jeffrey E Lancet and Mojdeh Naghashpour and Jane L Messina and Alan F. List and Lynn C. Moscinski and Ling Zhang}, journal={Leukemia research}, year={2012}, volume={36 1}, pages={72-80} }